Literature DB >> 20573814

Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1.

Andrea K Kress1, Grit Schneider, Klemens Pichler, Martina Kalmer, Bernhard Fleckenstein, Ralph Grassmann.   

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1), the cause of adult T-cell leukemia/lymphoma (ATLL), transforms CD4(+) T cells to permanent growth through its transactivator Tax. HTLV-1-transformed cells share phenotypic properties with memory and regulatory T cells (T-reg). Murine T-reg-mediated suppression employs elevated cyclic AMP (cAMP) levels as a key regulator. This led us to determine cAMP levels in HTLV-1-transformed cells. We found elevated cAMP concentrations as a consistent feature of all HTLV-1-transformed cell lines, including in vitro-HTLV-1-transformed, Tax-transformed, and patient-derived cells. In transformed cells with conditional Tax expression, high cAMP levels coincided with the presence of Tax but were lost without it. However, transient ectopic expression of Tax alone was not sufficient to induce cAMP. We found specific downregulation of the cAMP-degrading phosphodiesterase 3B (PDE3B) in HTLV-1-transformed cells, which was independent of Tax in transient expression experiments. This is in line with the notion that PDE3B transcripts and cAMP levels are inversely correlated. Overexpression of PDE3B led to a decrease of cAMP in HTLV-1-transformed cells. Decreased expression of PDE3B was associated with inhibitory histone modifications at the PDE3B promoter and the PDE3B locus. In summary, Tax transformation and its continuous expression contribute to elevated cAMP levels, which may be regulated through PDE3B suppression. This shows that HTLV-1-transformed cells assume biological features of long-lived T-cell populations that potentially contribute to viral persistence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573814      PMCID: PMC2918996          DOI: 10.1128/JVI.00487-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

Review 1.  Transcriptional and post-transcriptional gene regulation of HTLV-1.

Authors:  Fatah Kashanchi; John N Brady
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

Review 2.  Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions.

Authors:  Christophe Nicot; Robert L Harrod; Vincenzo Ciminale; Genoveffa Franchini
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

Review 3.  Molecular mechanisms of cellular transformation by HTLV-1 Tax.

Authors:  Ralph Grassmann; Mordechai Aboud; Kuan-Teh Jeang
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

Review 4.  Cellular immune response to HTLV-1.

Authors:  Charles R M Bangham; Mitsuhiro Osame
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

5.  Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells.

Authors:  Shuming Chen; Naoto Ishii; Shouji Ine; Syuichi Ikeda; Taku Fujimura; Lishomwa C Ndhlovu; Pejman Soroosh; Kohtaro Tada; Hideo Harigae; Junichi Kameoka; Noriyuki Kasai; Takeshi Sasaki; Kazuo Sugamura
Journal:  Int Immunol       Date:  2005-12-16       Impact factor: 4.823

6.  Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes.

Authors:  D Ekholm; J C Mulloy; G Gao; E Degerman; G Franchini; V C Manganiello
Journal:  Biochem Pharmacol       Date:  1999-09-15       Impact factor: 5.858

7.  Immunosuppressive factors from adult T-cell leukemia cells.

Authors:  F Shirakawa; Y Tanaka; S Oda; S Chiba; H Suzuki; S Eto; U Yamashita
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

8.  Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells.

Authors:  Tomoko Kohno; Yasuaki Yamada; Norihiko Akamatsu; Simeru Kamihira; Yoshitaka Imaizumi; Masao Tomonaga; Toshifumi Matsuyama
Journal:  Cancer Sci       Date:  2005-08       Impact factor: 6.716

9.  Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes.

Authors:  Katja Wäldele; Katrin Silbermann; Grit Schneider; Tobias Ruckes; Bryan R Cullen; Ralph Grassmann
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

10.  Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.

Authors:  Hideki Hasegawa; Hirofumi Sawa; Martha J Lewis; Yasuko Orba; Noreen Sheehy; Yoshie Yamamoto; Takeshi Ichinohe; Yasuko Tsunetsugu-Yokota; Harutaka Katano; Hidehiro Takahashi; Junichiro Matsuda; Tetsutaro Sata; Takeshi Kurata; Kazuo Nagashima; William W Hall
Journal:  Nat Med       Date:  2006-03-19       Impact factor: 53.440

View more
  6 in total

Review 1.  Cell surface markers in HTLV-1 pathogenesis.

Authors:  Andrea K Kress; Ralph Grassmann; Bernhard Fleckenstein
Journal:  Viruses       Date:  2011-08-16       Impact factor: 5.048

Review 2.  Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission.

Authors:  Christine Gross; Andrea K Thoma-Kress
Journal:  Viruses       Date:  2016-03-09       Impact factor: 5.048

3.  Neurally mediated syncope diagnosis based on adenylate cyclase activity in Japanese patients.

Authors:  Tomoyoshi Komiyama; Eiichiro Nagata; Tadashi Hashida; Susumu Sakama; Kengo Ayabe; Hiroshi Kamiguchi; Ayumi Sasaki; Koichiro Yoshioka; Hiroyuki Kobayashi
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

4.  Collagen IV (COL4A1, COL4A2), a Component of the Viral Biofilm, Is Induced by the HTLV-1 Oncoprotein Tax and Impacts Virus Transmission.

Authors:  Sebastian Millen; Christine Gross; Norbert Donhauser; Melanie C Mann; Jean-Marie Péloponèse; Andrea K Thoma-Kress
Journal:  Front Microbiol       Date:  2019-10-23       Impact factor: 5.640

5.  Diagnosis and prevention of the vasodepressor type of neurally mediated syncope in Japanese patients.

Authors:  Misaki Hasegawa; Tomoyoshi Komiyama; Kengo Ayabe; Susumu Sakama; Tetsuri Sakai; Kyong Hee Lee; Masahiro Morise; Atsuhiko Yagishita; Mari Amino; Ayumi Sasaki; Eiichiro Nagata; Hiroyuki Kobayashi; Koichiro Yoshioka; Yuji Ikari
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

6.  Meta-Analysis of HTLV-1-Infected Patients Identifies CD40LG and GBP2 as Markers of ATLL and HAM/TSP Clinical Status: Two Genes Beat as One.

Authors:  Eduardo Rocha Fukutani; Pablo Ivan Pereira Ramos; José Irahe Kasprzykowski; Lucas Gentil Azevedo; Moreno Magalhães de Souza Rodrigues; João Victor de Oliveira Pimenta Lima; Helton Fábio Santos de Araújo Junior; Kiyoshi Ferreira Fukutani; Artur Trancoso Lopo de Queiroz
Journal:  Front Genet       Date:  2019-11-08       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.